Skip to main content
. 2013 Dec 4;8(12):e77925. doi: 10.1371/journal.pone.0077925

Figure 3. In vivo treatment of stem cell donors affects antiviral response to peptide pools for CMV, EBV and ADV.

Figure 3

(A) Number of spot forming units (sfu) per well for untreated platelet and G-CSF-treated stem cell donors. (B) Number of sfu per 10,000 CD3+ cells for untreated and treated donors. (C) Response of pairs of stem cell donor cells to peptide pools of CMV, EBV and ADV before and after mobilization. Asterisks indicate significant differences (*p<0.05, **p<0.01, ***p<0.001). n.s. = not significant.